Company Jiangsu Jibeier Pharmaceutical Co., Ltd.

688566

CNE100004041

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Jiangsu Jibeier Pharmaceutical Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 28/04/2024 BST			5-day change	1st Jan Change
26.52 ^CNY	+1.80%		+19.89%	-15.51%

04-25	Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-08	Jibeier Pharmaceutical's Taxane Compound Method Gets Patent; Shares Down 3%	MT

Jiangsu Jibeier Pharmaceutical Co Ltd is a company engaged in the research, development, production and sales of drugs. The Company's products are comprised of tablets, capsules and eye drops. The tablet products include Leucogen tablets, Nitrendipine and Atenolol tablets, Aceclofenac Enteric-coated tablets and Asarone tablets. The Company's products are used to improve white blood cells, treat high blood pressure, eye infections and other diseases.

Number of employees: 1,016

CNY in Million	2021	Weight	2022	Weight	Delta
Pharmaceutical 100.0 %	510	100.0 %	655	100.0 %	+28.46%

CNY in Million	2021	Weight	2022	Weight	Delta
China 100.0 %	510	100.0 %	655	100.0 %	+28.46%

Managers	Title	Age	Since
Zhong yi Geng CEO	Chief Executive Officer	61	12/11/01
Suo Fu Zhao DFI	Director of Finance/CFO	57	07/05/17
Zheng Wang CHM	Chairman	47	12/11/01
Xiu Gen Wu CTO	Chief Tech/Sci/R&D Officer	59	30/06/08
Jin Chen BRD	Director/Board Member	46	13/09/20
Chun Zhang BRD	Director/Board Member	57	12/11/01
La Mei Li BRD	Director/Board Member	51	12/11/01
Xin Jun Yu BRD	Director/Board Member	63	12/11/01
Xiang Dong Cheng IRC	Investor Relations Contact	33	30/04/20
Zhao Guang Li PRN	Corporate Officer/Principal	43	30/11/15

Members of the board	Title	Age	Since
Guo Xiang Yang BRD	Director/Board Member	72	09/05/18
Zhu Yun Xie BRD	Director/Board Member	49	09/05/18
Zhong yi Geng CEO	Chief Executive Officer	61	12/11/01
Xin Jun Yu BRD	Director/Board Member	63	12/11/01
Tao Hu BRD	Director/Board Member	47	28/02/13
Di He BRD	Director/Board Member	56	09/05/18
Zheng Wang CHM	Chairman	47	12/11/01
La Mei Li BRD	Director/Board Member	51	12/11/01
Chun Zhang BRD	Director/Board Member	57	12/11/01
Jin Chen BRD	Director/Board Member	46	13/09/20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	189,083,976	46,440,948 ( 24.56 %)	0	24.56 %

Name	Equities	%	Valuation
Zhenjiang Zhongtian Investment Consulting Co. Ltd. 32.29 %	54,400,000	32.29 %	184 M ¥
Zhong yi Geng 30.75 %	51,806,200	30.75 %	175 M ¥
Da Cheng Fund Management Co., Ltd. 4.556 %	7,676,005	4.556 %	26 M ¥
Bank of China Investment Management Co., Ltd. 0.8185 %	1,379,136	0.8185 %	5 M ¥
Aegon-Industrial Fund Management Co., Ltd. 0.4737 %	798,091	0.4737 %	3 M ¥
Hwabao WP Fund Management Co., Ltd. 0.4049 %	682,281	0.4049 %	2 M ¥
Huatai Securities (Shanghai) Asset Management Co., Ltd. 0.3859 %	650,134	0.3859 %	2 M ¥
HuaAn Fund Management Co., Ltd. 0.2086 %	351,401	0.2086 %	1 M ¥
Minsheng Royal Fund Management Co., Ltd. 0.1793 %	302,100	0.1793 %	1 M ¥
Nuode Asset Management Co., Ltd. 0.1700 %	286,450	0.1700 %	967 854 ¥

Jiangsu Jibeier Pharmaceutical Co. Ltd.

High-Tech Industrial Dev Park

212000, Zhenjiang

http://www.jbepharm.com

address Jiangsu Jibeier Pharmaceutical Co., Ltd.(688566)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

26.52

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.	-15.51%	680M
MERCK KGAA	+4.06%	70.44B
KYOWA KIRIN CO. LTD.	+10.97%	8.94B
SK BIOPHARMACEUTICALS CO., LTD.	-14.44%	4.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+41.60%	4.5B
YUHAN CORPORATION	+5.96%	3.85B
INDIVIOR PLC	+23.46%	2.38B
BETTA PHARMACEUTICALS CO., LTD.	-19.32%	2.34B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-27.04%	2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+7.97%	1.96B

Specialty & Advanced Pharmaceuticals